Frequency of T۳۱۵I Mutation in Patients with Chronic Myeloid Leukemia Before and During Imatinib Treatment: A Study in North-East of Iran
نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
تاریخ نمایه سازی: 10 آبان 1402
Abstract:
Keywords:
Authors
Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Dept. of Hematology, School of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran
School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Dept. of Hematology and Blood Banking, Faculty of Medicine, Gonabad University of Medical Sciences, Gonabad, Iran
مراجع و منابع این Paper: